Product Information
CLINDAMYCIN-BNZ PEROX 1-5% PMP is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $1.1278 per GM under NDC 45802051003. Its NADAC has been published 287 times since Apr 7, 2021.
FDA first approved this application on Sep 21, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802051003
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202440FDA Approved
9/21/2015
TE Code
AB
On Market Since
3/8/2021
Price Statistics
The NADAC for CLINDAMYCIN-BNZ PEROX 1-5% PMP has been published 287 times since Apr 7, 2021, and over the history we have for it it has declined 62.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1278 per GM |
|---|---|
| All-time high | $4.6194 (Jun 16, 2021) |
| All-time low | $0.6632 (Jan 17, 2024) |
| 52-week high | $1.2319 |
| 52-week low | $1.0931 |
| Median price | $1.2223 |
| Average price | $1.4698 |
| Largest weekly change | +83.2% (Apr 17, 2024) |
| Weeks tracked | 287 |
| Tracking since | Apr 7, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin and benzoyl peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN-BNZ PEROX 1-5% PMP?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN-BNZ PEROX 1-5% PMP, manufactured by Padagis Israel Pharmaceuticals Ltd, is $1.1278 per GM (NDC 45802051003), effective Sep 30, 2026.
How has the price of CLINDAMYCIN-BNZ PEROX 1-5% PMP changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN-BNZ PEROX 1-5% PMP has declined 62.1%. It has been tracked across 287 weekly CMS publications since Apr 7, 2021.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN-BNZ PEROX 1-5% PMP?
Since Apr 7, 2021, the NADAC for CLINDAMYCIN-BNZ PEROX 1-5% PMP has ranged from a low of $0.6632 (Jan 17, 2024) to a high of $4.6194 (Jun 16, 2021), with a median of $1.2223 per GM.
Are there cheaper alternatives to CLINDAMYCIN-BNZ PEROX 1-5% PMP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN-BENZOYL PEROX 1-5%, is $0.5007 per GM — about 56% below CLINDAMYCIN-BNZ PEROX 1-5% PMP.
Who manufactures CLINDAMYCIN-BNZ PEROX 1-5% PMP?
CLINDAMYCIN-BNZ PEROX 1-5% PMP (NDC 45802051003) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.